Literature DB >> 34059544

Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.

Omar Fueyo-Rodriguez1, Benjamin Valente-Acosta2, Rodolfo Jimenez-Soto1, Yvette Neme-Yunes1, Sergio Ignacio Inclán-Alarcón1, Roxana Trejo-Gonzalez1, Miguel Ángel García-Salcido3.   

Abstract

Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer-BioNTech). © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  COVID-19; immunological products and vaccines

Year:  2021        PMID: 34059544     DOI: 10.1136/bcr-2021-242220

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis.

Authors:  Hind A ElSawi; Ahmed Elborollosy
Journal:  Egypt J Intern Med       Date:  2022-05-19

2.  A Three-Case Series of Thrombotic Deaths in Patients over 50 with Comorbidities Temporally after modRNA COVID-19 Vaccination.

Authors:  Luca Roncati; Antonio Manenti; Lorenzo Corsi
Journal:  Pathogens       Date:  2022-04-03

3.  Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination.

Authors:  Yuta Baba; Hirotaka Sakai; Nobuyuki Kabasawa; Hiroshi Harada
Journal:  Intern Med       Date:  2022-04-09       Impact factor: 1.282

4.  Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection.

Authors:  Po-Wei Liao; Chieh-Lin Jerry Teng; Cheng-Wei Chou
Journal:  Vaccines (Basel)       Date:  2021-12-16

5.  Cardiovascular and haematological events post COVID-19 vaccination: A systematic review.

Authors:  Dana Al-Ali; Abdallah Elshafeey; Malik Mushannen; Hussam Kawas; Ameena Shafiq; Narjis Mhaimeed; Omar Mhaimeed; Nada Mhaimeed; Rached Zeghlache; Mohammad Salameh; Pradipta Paul; Moayad Homssi; Ibrahim Mohammed; Adeeb Narangoli; Lina Yagan; Bushra Khanjar; Sa'ad Laws; Mohamed B Elshazly; Dalia Zakaria
Journal:  J Cell Mol Med       Date:  2021-12-29       Impact factor: 5.310

6.  Relapse of immune thrombocytopenia after COVID-19 vaccination.

Authors:  Wobke E M van Dijk; Roger E G Schutgens
Journal:  Eur J Haematol       Date:  2021-10-17       Impact factor: 2.997

7.  BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura.

Authors:  A K Ghosh; S Bhushan; L D R Lopez; D Sampat; Z Salah; C A Hatoum
Journal:  Case Rep Med       Date:  2022-04-12

8.  Clinical spectrum of gross haematuria following SARS-CoV-2 vaccination with mRNA vaccines.

Authors:  Alexander Ritter; Birgit Helmchen; Ariana Gaspert; Joerg Bleisch; Barbara Fritschi; Florian Buchkremer; Stephanie Damm; Nicolas Schmid; Thomas Schachtner; Harald Seeger
Journal:  Clin Kidney J       Date:  2021-12-21

9.  Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine.

Authors:  Josef Finsterer; Maria Korn
Journal:  Brain Hemorrhages       Date:  2021-06-24

10.  Severe immune thrombocytopenia following COVID-19 vaccination (Moderna) and immune checkpoint inhibitor.

Authors:  Kah-Meng Chong; Ching-Yao Yang; Chien-Chin Lin; Wan-Ching Lien
Journal:  Am J Emerg Med       Date:  2022-03-18       Impact factor: 4.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.